Evaluation of efficacy and safety of adjuvant Ayurvedic therapy in patients with severe post-covid mucor-mycosis at a Government tertiary care hospital - A Case-Control study.

While contemporary non-study patients at the same institution reported above 20% recurrence rates across all groups [mild, moderate and severe], the control group reports a 20.7% recurrence, with PTGG based intervention group showing only 2.8%, which was statistically highly significant on the ANOVA and Chi-square test for equality of variances. 3.5 Progression of the disease Patients who used PTGG regime for more than 7 days showed no progression [0%] against the comparison group [24.1%] which was also found to be statistically significant on both tests. 3.6 Mortality rate The most striking benefit seen in the PTGG intervention group, was with regards to the decreased rate of mortality.

also in 132,142 other papers